Midgard

Aptamer Group

York, United Kingdom aptamergroup.com From their website, Nov 2026

Work here? Claim this listing

About

Aptamer Group develops custom Optimer® aptamer binders and related assay solutions for life sciences customers. It works with global pharmaceutical, diagnostic, biotech, and bioprocessing organizations from its York, UK site.

Services

  • Custom Optimer® development

    Custom solutions using the Optimer® affinity platform to solve targeting challenges from early discovery through clinical development.

  • Biomarker discovery service

    Discovery and validation of novel biomarkers by comparing healthy and diseased cell phenotypes, including cell-surface and intracellular protein targets.

  • Custom development workflow

    A staged workflow covering consultation, in vitro selection, clonal analysis and Optimer development, assay development, and supply.

  • Bioprocessing solutions

    Optimer-based affinity purification and quality control reagents for bioprocessing and manufacturing workflows.

  • Assay development

    Characterisation, validation, and development of application-ready assays for custom Optimer binders.

  • Custom bioanalytical reagents

    Development of Optimer reagents as antibody alternatives for detection and quantification assays in plasma, serum, or tissue.

  • Optimer binders to license

    Optimer binders available to trial or license with custom modifications for platform integration.

  • Optimer® binder licensing

    Provides Optimer® binders available to trial or license with custom modifications for platform integration.

2 more services
  • Therapeutics development
  • Diagnostics and reagents
Turnaround
From weeks to months

Capabilities

Assays and studies
  • ELISA
  • SPR
  • BLI
  • Flow cytometry
  • FACS
  • Cell-based inhibition/activation assays
10 more
  • Affinity chromatography
  • WB
  • Fluorescence microscopy
  • IHC
  • Luminex
  • Enzyme activity assays
  • Immunocytochemistry
  • Cell viability and proliferation assays
  • Apoptosis and internalisation assays
  • Biolayer interferometry
Scale and capacity
Manufacturing scale
Therapeutic areas
  • Therapeutics
  • Diagnostics
  • Bioprocessing
  • Drug delivery
  • Biomarker discovery
  • Oncology
4 more
  • Neurology
  • Metabolism
  • Radiopharmaceuticals
  • Alzheimer's disease

Instruments and platforms

  • Octet RH16
  • Biolayer interferometry
  • Mass spectrometry

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • Peptide
  • Oligonucleotide
Species and models
  • Cells
  • Primary fibrotic liver cells
  • Primary fibrotic hepatic stellate cells
  • Healthy cells
  • Diseased cells
  • Cancer cells
5 more
  • Healthy vs diseased cell models
  • Cancer vs healthy
  • Resistant vs sensitive
  • Activated vs quiescent
  • Liquid biopsies

Industries served

  • Pharmaceutical
  • Diagnostic
  • Biotech
  • Bioprocessing
  • Consumer cosmetic

Details

Quality
ICH M10 (bioanalytical method validation guideline naming aptamers among binding reagents)
Office
29 Wellington Street Leeds LS1 4DL All enquiries concerning your shareholding should be di
Serves
Global
General enquiry
info@aptamergroup.com on their site
Phone
+44 (0) 1904217404

Public records

Parent company
APTAMER GROUP PLC · GB GLEIF

Similar labs